Serge Belanger
Stock Analyst at Needham
(4.24)
# 415
Out of 4,944 analysts
370
Total ratings
53.76%
Success rate
13.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Upgrades: Buy | $36 | $30.35 | +18.62% | 6 | Aug 12, 2025 | |
| HRTX Heron Therapeutics | Maintains: Buy | $4 → $3 | $1.31 | +129.01% | 23 | Aug 8, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $24 → $22 | $7.33 | +200.14% | 22 | Aug 8, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $20 → $22 | $14.74 | +49.25% | 22 | Aug 7, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $36 → $34 | $17.97 | +89.20% | 18 | Aug 6, 2025 | |
| EOLS Evolus | Downgrades: Hold | $22 | $6.40 | +243.75% | 16 | Aug 6, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $15 | $12.48 | +20.24% | 4 | Aug 5, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $17 | $8.35 | +103.59% | 16 | Aug 4, 2025 | |
| CLSD Clearside Biomedical | Downgrades: Hold | $3 | $0.43 | +591.24% | 16 | Jul 17, 2025 | |
| CRMD CorMedix | Maintains: Buy | $15 → $20 | $11.50 | +73.91% | 18 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $25.00 | +60.00% | 9 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $32 | $24.10 | +32.78% | 32 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.18 | - | 7 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.82 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $34.31 | +109.85% | 23 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $66 | $54.84 | +20.35% | 13 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $55 | $35.99 | +52.82% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $24.81 | +20.92% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.79 | +123.46% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $37.87 | +21.47% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $12.25 | +128.57% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.32 | - | 1 | Mar 31, 2022 |
Amphastar Pharmaceuticals
Aug 12, 2025
Upgrades: Buy
Price Target: $36
Current: $30.35
Upside: +18.62%
Heron Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.31
Upside: +129.01%
Trevi Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $7.33
Upside: +200.14%
Arcutis Biotherapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $14.74
Upside: +49.25%
Viridian Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $17.97
Upside: +89.20%
Evolus
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $6.40
Upside: +243.75%
Ocular Therapeutix
Aug 5, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $12.48
Upside: +20.24%
BioCryst Pharmaceuticals
Aug 4, 2025
Maintains: Buy
Price Target: $17
Current: $8.35
Upside: +103.59%
Clearside Biomedical
Jul 17, 2025
Downgrades: Hold
Price Target: $3
Current: $0.43
Upside: +591.24%
CorMedix
Jun 24, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $11.50
Upside: +73.91%
Jun 12, 2025
Reiterates: Buy
Price Target: $40
Current: $25.00
Upside: +60.00%
Jun 2, 2025
Maintains: Buy
Price Target: $25 → $32
Current: $24.10
Upside: +32.78%
May 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.18
Upside: -
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.82
Upside: -
May 14, 2025
Reiterates: Buy
Price Target: $72
Current: $34.31
Upside: +109.85%
May 13, 2025
Reiterates: Buy
Price Target: $66
Current: $54.84
Upside: +20.35%
May 13, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $35.99
Upside: +52.82%
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $24.81
Upside: +20.92%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.79
Upside: +123.46%
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $37.87
Upside: +21.47%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $12.25
Upside: +128.57%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $3.32
Upside: -